Bifidobacterium breve BB077 (LMG P-30157)

Discover characteristics, functionalities and scientific support of Bifidobacterium breve BB077 (LMG P-30157).

Anti-inflammatory activity Lactose digestion

Thearapeutical Area(s): Gastrointestinal tract, Gut brain Axis

Age/Gender: Adults

Available at

SynBalance SRL

Formulation, Probiotic Strains

Bifidobacterium breve BB077 (LMG P-30157), developed by SynBalance.
Gastrointestinal Health • Cognitive function• Immune prevention

Probiotic blends with Bifidobacterium breve BB077 (LMG P-30157)

SynbÆctive® KeepCalm

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Bifidobacterium breve BB077 (LMG P-30157)

SynBalance SRL

Scientific reference(s)

Probiotic blends with Bifidobacterium breve BB077 (LMG P-30157)

SynbÆctive® AllergAway

SynbÆctive® KeepCalm